A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

In the ever-evolving landscape of healthcare, groundbreaking innovations are not merely celebrated for their scientific ...

Three U.S. senators are calling on Robert Kennedy Jr. to disclose what he and President Trump discussed with drugmakers ...

Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and ...

A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture ...

Lily flowers, a commonly used ingredient in Chinese cooking, have been voluntarily recalled due to undeclared sulfites, which ...

Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and it's an element you can count on ...

Eli Lilly and Incyte's baricitinib showed significant hair regrowth in adolescents with severe alopecia areata, with results ...

Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.

Also Read: Eli Lilly’s Single Monthly Maintenance Shot Of Eczema Drug Shows Completely Clear Skin At 3 Years In 50% Of Trial Patients Results achieved by adolescents at 36 weeks were comparable ...

"The size is significant. We're talking about 900 million patients that could benefit from Mounjaro," Montarce said at the ...